The Patent Finder

Terms ending in 2043

Pharma Cinq, LLC

Every in-force patent on Pharma Cinq, LLC's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,577,2702',3'-Diacetyluridine Substituted With Acetoacetyl at the 5' Position
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
US 12,649,739Imidazoquinoline Compound Having Anti-Inflammatory, Antifugal, Antiparasitic, and Anticancer Activity
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
US 12,703,718Compositions and Compounds for Co-Delivery of Uridine and Ketoleucine
In force
 · High confidence
Pharma Cinq, LLCIn forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited